Spotitearly

Tel Aviv, Israel Founded: 2020 • Age: 6 yrs
AI-based cancer detection device for providers

About Spotitearly

Spotitearly is a company based in Tel Aviv (Israel) founded in 2020 by Ohad Sharon.. Spotitearly has raised $6.21 million across 2 funding rounds from investors including Hanaco Ventures, Jeff Schwartz and Michael Eisenberg. Spotitearly offers products and services including Cancer Pre-Screening, BRCA Germline, Bio-Hybrid Platform, and Bio-Sensors. Spotitearly operates in a competitive market with competitors including Panakeia, Boston Medical Sciences, Nevia Bio, SquareMind and Onkolyze, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Ohad Sharon
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.21 M (USD)

    in 2 rounds

  • Latest Funding Round
    $10 K (USD), Seed

    Jul 21, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spotitearly

Spotitearly offers a comprehensive portfolio of products and services, including Cancer Pre-Screening, BRCA Germline, Bio-Hybrid Platform, and Bio-Sensors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Breath-based at-home test for early detection of multiple cancers.

Test for inherited gene mutations linked to cancer risks.

Integrates biosensors and AI for breath sample analysis.

Devices that identify cancer-related compounds in breath.

People of Spotitearly
Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Udi Bobrovsky
Co-founder & COO
People
Ohad Sharon
Co-founder & CSO (strategy)

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Spotitearly

Spotitearly has successfully raised a total of $6.21M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $10 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $10,000
  • First Round

    (23 Jun 2022)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Seed - Spotitearly Valuation

investors

Jun, 2022 Amount Seed - Spotitearly Valuation Hanaco Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Spotitearly

Spotitearly has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Hanaco Ventures, Jeff Schwartz and Michael Eisenberg. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Startups are funded through venture capital by Hanaco Ventures.
Founded Year Domain Location

Jeff Schwartz

Angel investor in Indian startups, focused on tech and innovation.
Founded Year Domain Location

Michael Eisenberg

-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Spotitearly

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Spotitearly

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Spotitearly Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Spotitearly

Spotitearly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Panakeia, Boston Medical Sciences, Nevia Bio, SquareMind and Onkolyze, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-based software is provided for cancer diagnosis and precision treatment.
domain founded_year HQ Location
AI-powered colorectal cancer screening system
domain founded_year HQ Location
Machine learning-enabled platform for early detection of women-related diseases
domain founded_year HQ Location
Developer of robotic medical equipment for skin cancer detection
domain founded_year HQ Location
Ultrasound images are analyzed by AI platform for cancer detection.
domain founded_year HQ Location
Portable digital device for cervical exams, risk assessment, and telemedicine integration.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Spotitearly

Frequently Asked Questions about Spotitearly

When was Spotitearly founded?

Spotitearly was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Spotitearly located?

Spotitearly is headquartered in Tel Aviv, Israel.

Is Spotitearly a funded company?

Spotitearly is a funded company, having raised a total of $6.21M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6.2M, raised on Jun 23, 2022.

What does Spotitearly do?

AI-based cancer detection device for providers. The company has developed a screening test mask that can be used for screening different stages and kinds of cancer based on its odor. It has features for real-time analysis, an AI system for detection, and more.

Who are the top competitors of Spotitearly?

Spotitearly's top competitors include Inocras, Panakeia and Boston Medical Sciences.

What products or services does Spotitearly offer?

Spotitearly offers Cancer Pre-Screening, BRCA Germline, Bio-Hybrid Platform, and Bio-Sensors.

Who are Spotitearly's investors?

Spotitearly has 3 investors. Key investors include Hanaco Ventures, Jeff Schwartz, and Michael Eisenberg.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available